Cytokinetics CYTK Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$206.03M-27.7% | -$183.03M-22.0% | -$306.18M-90.7% | -$134.37M+6.2% | -$161.38M-19.0% | ||
| $3.38M+46.9% | $2.86M+20.1% | $2.68M+11.1% | $2.29M-5.0% | $2.3M-1.3% | ||
| $30.39M+29.1% | $30.51M+16.2% | $30.7M+21.1% | $27.54M+11.8% | $23.55M+9.0% | ||
| -$145.46M-10.5% | -$142.65M-118% | -$107.51M-5.9% | -$128.24M-29.1% | -$131.62M-1.6% | ||
| $5.93M+4.7% | $5.64M+338% | $9.35M+1,234% | $4.15M+116% | $5.66M— | ||
| $145.49M+37.3% | —— | —— | $52.88M+108% | $105.96M+225% | ||
| —— | $182.37M— | $182.37M— | $182.37M— | $182.37M— | ||
| $2.74M+2.0% | $2.72M+1.9% | $2.71M+1.9% | $2.7M+1.9% | $2.68M+280% | ||
| $7.77M+63.4% | $110.71M+4,544% | $330.47M+9,549% | $78.53M-90.4% | $4.75M-95.4% | ||
| $7.32M+135% | —— | $152.03M+206% | —— | -$21.18M-405% | ||
| -$151.39M-10.3% | -$148.3M-122% | -$116.86M-14.3% | -$132.38M-30.8% | -$137.28M-6.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cytokinetics generate?
- Cytokinetics (CYTK) generated -$523.8M in operating cash flow over the trailing twelve months.
- What is Cytokinetics's free cash flow?
- After $25.1M of capital expenditures, Cytokinetics's free cash flow was -$548.9M over the trailing twelve months, down 34.7% year over year.
- Where does Cytokinetics's cash flow data come from?
- Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
